Streetbeat News

Stock Prices

PACB

Pacific Biosciences (NASDAQ:PACB) has received mixed analyst ratings in the last quarter, with 2 bullish and 2 indifferent ratings. The average 12-month price target for the company has increased by 17.31% from the previous average of $13.00 to $15.25.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 1:57 pm

UTHR

United Therapeutics (NASDAQ:UTHR) has received four analyst ratings in the last quarter, all of which were either bullish or somewhat bullish. The average 12-month price target for the company, according to these analysts, is $298.25, a figure that has increased by 2.03% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 1:57 pm

COOK

Traeger reported better-than-expected Q2 financial results, leading to a rise in its share prices. Tesley Advisory Group upgraded the stock from Market Perform to Outperform and raised its price target from $3.5 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:56 pm

APO

Apollo Global Management reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:56 pm

STE

Morgan Stanley has maintained its Equal-Weight rating for Steris (NYSE:STE) and increased its price target from $206.00 to $225.00. Steris shares are currently trading down 0.96% at $225.62 per share. Steris is a medical device company focused on sterilization services and infection prevention, with 70% of its revenue derived from U.S. operations.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 1:56 pm

U

Unity Software Inc (NYSE:U) reported Q2 results with revenue increasing over 80% YoY to $533.48 million, beating consensus estimates. The company also reported a quarterly loss of 51 cents per share. Adjusted EBITDA was $99 million, an improvement of $136 million YoY. Unity raised its full-year guidance range by $40 million, with new full-year revenue guidance of $2.12 billion to $2.2 billion. Several analysts raised price targets on the stock following the results.

Portfolio Pulse from Adam Eckert

August 04, 2023 | 1:56 pm

CLX

CMI

COOK

DXC

EXPE

UPWK

Numerous stocks experienced significant price changes in Thursday's mid-day session. Companies that posted strong quarterly results, such as Traeger, Inc. (COOK), Upwork Inc. (UPWK), and The Clorox Company (CLX), saw their shares rise. Conversely, companies that reported worse-than-expected results or issued below-consensus outlooks, such as DXC Technology Company (DXC), Expedia Group, Inc. (EXPE), and Cummins Inc. (CMI), saw their shares fall.

Portfolio Pulse from Lisa Levin

August 04, 2023 | 1:56 pm

MIRA

Pre-clinical-stage biopharma company, MIRA Pharmaceuticals, has launched its initial public offering on NASDAQ. The company is developing a synthetic THC prescription drug, MIRA1a, to treat anxiety, pain, and cognition disorders without the side effects of cannabis or opioids. If approved by the FDA, MIRA1a could advance the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders.

Portfolio Pulse from Nina Zdinjak

August 04, 2023 | 1:56 pm

HOOD

Robinhood's shares have moved lower as the company is seeking a financial data firm to build an in-app trading hub. The move is expected to enhance the trading experience for its users.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:56 pm

ABNB

A large bearish position has been taken on Airbnb (NASDAQ:ABNB), with 23 uncommon options trades spotted, split between 26% bullish and 73% bearish. The total amount for puts is $958,270 and for calls is $489,381. Whales have been targeting a price range from $125.0 to $170.0 for Airbnb over the last 3 months. The price of ABNB is down -2.35% at $141.16. Analysts from Morgan Stanley, Needham, Keybanc, Argus Research, and B of A Securities have maintained their ratings on Airbnb.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 1:55 pm